Financial reports
10-K/A
2023 FY
Annual report (amended)
18 Mar 24
10-K
2023 FY
Annual report
14 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
5 May 23
10-K
2022 FY
Annual report
20 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
30 Jun 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Mar 24
8-K
Departure of Directors or Certain Officers
16 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Jan 24
8-K
Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing
20 Dec 23
8-K
Entry into a Material Definitive Agreement
14 Dec 23
8-K
Entry into a Material Definitive Agreement
16 Nov 23
8-K
Departure of Directors or Certain Officers
1 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5 Oct 23
8-K/A
Departure of Directors or Certain Officers
26 Sep 23
8-K
Departure of Directors or Certain Officers
31 Aug 23
Registration and prospectus
424B3
Prospectus supplement
24 Jan 24
S-8
Registration of securities for employees
16 Jan 24
S-3
Shelf registration
12 Jan 24
D
$9.19 mm in equity / debt / options / securities to be acquired, sold $7.79 mm, 19 investors
19 Dec 23
424B3
Prospectus supplement
23 Aug 23
S-3
Shelf registration
14 Aug 23
D
$8.72 mm in equity / debt / options / securities to be acquired, sold $8.72 mm, 19 investors
26 Jul 23
D
$8.72 mm in equity / debt / options / securities to be acquired, sold $8.72 mm, 19 investors
26 Jul 23
424B3
Prospectus supplement
25 Apr 23
S-1
IPO registration
14 Apr 23
Proxies
DEFA14A
Additional proxy soliciting materials
9 May 23
DEFA14A
Additional proxy soliciting materials
5 May 23
DEF 14A
Definitive proxy
5 May 23
PRE 14A
Preliminary proxy
20 Apr 23
DEFA14A
Additional proxy soliciting materials
12 Aug 22
DEF 14A
Definitive proxy
12 Aug 22
PRE 14A
Preliminary proxy
2 Aug 22
DEFA14A
Additional proxy soliciting materials
31 May 22
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
Other
EFFECT
Notice of effectiveness
23 Jan 24
CORRESP
Correspondence with SEC
18 Jan 24
UPLOAD
Letter from SEC
17 Jan 24
EFFECT
Notice of effectiveness
23 Aug 23
CORRESP
Correspondence with SEC
18 Aug 23
UPLOAD
Letter from SEC
17 Aug 23
EFFECT
Notice of effectiveness
25 Apr 23
CORRESP
Correspondence with SEC
20 Apr 23
UPLOAD
Letter from SEC
20 Apr 23
EFFECT
Notice of effectiveness
21 Mar 23
Ownership
3
Peter Cicala
16 Feb 24
SC 13G/A
HALPERN JOHN D
31 Jan 24
SC 13G/A
Singer Nicholas Jason
19 Jan 24
4
Sanjeev Luther
3 Jan 24
4
Dorothy J Clarke
3 Jan 24
3
Sanjeev Luther
3 Jan 24
SC 13D/A
Cherington Charles
22 Dec 23
SC 13G
IAF, LLC
20 Dec 23
4
Charles Cherington
20 Dec 23
4
CURTIS W HUFF
18 Dec 23